[(68)Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up?

BACKGROUND: The aim of the current study was to assess whether and to what extent monitoring response to treatment using prostate-specific membrane antigen (PSMA)-based positron-emitting tomography/computerized tomography (PET/CT) studies contribute clinically relevant data to routine clinical follo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuten, Jonathan, Sarid, David, Yossepowitch, Ofer, Mabjeesh, Nicola J., Even-Sapir, Einat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715755/
https://www.ncbi.nlm.nih.gov/pubmed/31468235
http://dx.doi.org/10.1186/s13550-019-0554-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715755/
https://www.ncbi.nlm.nih.gov/pubmed/31468235
http://dx.doi.org/10.1186/s13550-019-0554-1

Ejemplares similares